| Literature DB >> 25670027 |
Yuqing Huang1, Zhiyong Zhang1, Hao Chen1, Jianghua Feng1, Shuhui Cai1, Zhong Chen1.
Abstract
NMR spectroscopy is a commonly used technique for metabolite analyses. Due to the observed macroscopic magnetic susceptibility in biological tissues, current NMR acquisitions in measurements of biological tissues are generally performed on tissue extracts using liquid NMR or on tissues using magic-angle spinning techniques. In this study, we propose an NMR method to achieve high-resolution J-resolved information for metabolite analyses directly from intact biological samples. A dramatic improvement in spectral resolution is evident in our contrastive demonstrations on a sample of pig brain tissue. Metabolite analyses for a postmortem fish from fresh to decayed statuses are presented to further reveal the capability of the proposed method. This method is a previously-unreported high-resolution 2D J-resolved spectroscopy for biological applications without specialised hardware requirements or complicated sample pretreatments. It provides a significant contribution to metabolite analyses of biological samples, and may be potentially applicable to in vivo samples. Furthermore, this method also can be applied to measurements of semisolid and viscous samples.Entities:
Mesh:
Year: 2015 PMID: 25670027 PMCID: PMC4323641 DOI: 10.1038/srep08390
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Illustration of the DDFJRES processing using the data from a GABA aqueous solution.
(a) 1D proton spectrum with expanded multiplets in a well-shimmed homogeneous field (the black solid line) and in an inhomogeneous field where the FWHM of water resonance was deliberately degraded to 200 Hz (the red dotted line). (b) 3D DDFJRES data presented as stacked 1D spectra along the F3 frequency domain. (c) A batch of 2D spectra after data processing in F1 and F3 dimensions. (d) 2D spectra corresponding to (c) after a shearing process. (e) High-resolution 2D JRES spectrum constructed using F2 and F3 dimensions after 2D projection along the F1 dimension. The molecular structure of GABA is shown on the top right of the frame, together with observable protons marked by a dotted box.
Figure 2Contrastive NMR results on pig brain tissue.
(a) 1D water-presaturated spectrum of the tissue extraction. (b) 2D water-presaturated JRES spectrum of the tissue extraction and its projection along the F2 axis. (c) 1D water-presaturated MAS spectrum of the tissue packed in a 4-mm ZrO2 rotor acquired using a Nano probe. (d) 2D water-presaturated JRES spectrum and its projection along the F2 axis; (e) 2D DDFJRES spectrum and its 1D J-decoupled projection along the F3 axis. The sample for (d) and (e) is a piece of intact tissue fitted in a 5-mm NMR tube. The spectral region from 5.40 to 9.00 ppm is expanded for (a), (b), and (c). Assigned metabolites are marked in (a), (b), (c), and (e), respectively.
Assignments of 2D JRES spectrum from the pig brain tissue extraction, 2D DDFJRES spectrum from a piece of intact pig brain tissue, and 1D MAS spectrum from the pig brain tissue
| Metabolites | Groups | 1H chemical shifts (ppm) | Multiplet patterns | |
|---|---|---|---|---|
| Isoleucine (Ile) | -CH3 | 0.92/n.o./n.o. | t/n.o./n.o. | 7.4/n.o./n.o. |
| -CH3 | 0.99/n.o./n.o. | d/n.o./n.o. | 7.1/n.o./n.o. | |
| Leucine (Leu) | -CH3 | 0.95/n.o./n.o. | t/n.o./n.o. | 6.0/n.o./n.o. |
| Valine (Val) | -CH3 | 0.94/0.94/0.93 | d/d/d | 7.2/7.1/7.1 |
| -CH3 | 1.02/n.o./n.o. | d/n.o./n.o. | 7.2/n.o./n.o. | |
| Lactate (Lac) | -CH-C | 1.31/1.31/1.31 | d/d/d | 7.1/7.1/7.2 |
| -C | 4.09/4.09/4.10 | q/q/q | 7.1/7.1/n.o. | |
| Alanine (Ala) | -CH3 | 1.46/1.48/1.47 | d/d/d | 7.2/7.3/7.2 |
| Acetate (Ace) | -CH3 | 1.90/1.91/1.90 | s/s/s | -/-/- |
| N-Acetyl aspartate (NAA) | -CH3 | 2.00/2.01/2.00 | s/s/s | -/-/- |
| -CH-C | 2.67/2.69/2.68 | dd/dd/dd | 4.1,15.6/3.9,15.6/4.1,15.8 | |
| -C | 4.38/n.o./4.38 | m/n.o./m | 4.0/n.o./3.8 | |
| NAAG | -CH3 | 2.04/n.o./2.05 | s/n.o./s | -/n.o./- |
| γ-Aminobutyric acid (GABA) | -CH2-C | 1.88/n.o./1.89 | m/n.o./n.o. | 7.4/n.o./n.o. |
| -C | 2.28/2.29/2.29 | t/t/t | 7.4/7.4/7.3 | |
| -CH2 | 3.00/n.o./3.01/ | t/n.o./t. | 7.1/n.o./7.0 | |
| Glutamate/Glutamine (Glu/Gln) | -CH2 | 2.05/n.o./n.o. | m/n.o./n.o. | 7.4/n.o./n.o. |
| -CH2 | 2.08/n.o./n.o. | m/n.o./n.o. | 7.3,12.4/n.o./n.o. | |
| -CH2 | 2.11/2.11/2.11 | m/m/m | 7.6/7.8/7.4 | |
| -CH2 | 2.33/2.34/2.33 | m/m/m | 3.5,7.1/3.4,7.3/7.6 | |
| -CH2 | 2.48/2.49/2.48 | m/m/m | 7.6/7.4/7.3 | |
| -CH | 3.74/3.77/3.77 | dd/dd/dd | 6.0,9.5/6.0,9.9/6.6,9.7 | |
| Succinate (Suc) | -CH2 | 2.41/2.41/2.43 | s/s/s | -/-/- |
| Aspartate (Asp) | -CH | 2.79/2.81/2.80 | dd/dd/dd | 4.2,17.6/4.4,17.7/4.4,17.8 |
| Creatine (Cr) | -CH3 | 3.01/3.01/3.02 | s/s/s | -/-/- |
| -CH2 | 3.91/3.91/3.91 | s/s/s | -/-/- | |
| Cho/PC/GPC | -CH3 | 3.19/3.20/3.19 | s/s/s | -/-/- |
| Cho | -CH2 | 4.10/n.o./n.o. | m/n.o./n.o. | 4.1,8.4/n.o./n.o. |
| PC | -CH2 | 4.21/n.o./n.o. | dd/n.o./n.o. | 4.2,7.7/n.o./n.o. |
| Ethanolamine (EA) | -CH2 | 3.13/n.o./3.14 | t/n.o./t | 5.4/n.o./5.5 |
| -CH | 3.26/3.28/3.27 | t/t/t | 9.2/9.2/9.3 | |
| -CH | 3.52/3.53/3.52 | dd/t/t | 3.0,10.3/10.3/10.4 | |
| -CH | 3.60/3.61/3.61 | t/t/t | 9.9/9.8/9.7 | |
| -CH | 4.05/4.06/4.06 | s/s/s | -/-/- | |
| -CH | 3.33/3.35/3.34 | s/s/s | -/-/- | |
| Taurine (Tau) | -CH2 | 3.40/3.41/3.41 | t/t/t | 6.9/6.8/6.7 |
| U-Glc | -CH | 5.59/n.o./n.o. | d/n.o./n.o. | 5.9/n.o./n.o. |
| Uridine(Ud) | -CH | 5.88/n.o./n.o. | d/n.o./n.o. | 8.1/n.o./n.o. |
| -CH | 5.91/n.o./n.o. | d/n.o./n.o. | 4.6/n.o./n.o. | |
| -CH | 7.87/n.o./n.o. | d/n.o./n.o. | 8.1/n.o./n.o. | |
| Adenosine (Ade) | -CH | 6.07/n.o./n.o. | d/n.o./n.o. | 6.0/n.o./n.o. |
| -CH | 8.16/n.o./n.o. | s/n.o./n.o. | -/n.o./n.o. | |
| -CH | 8.30/n.o./n.o. | s/n.o./n.o. | -/n.o./n.o. | |
| Fumaric acid (Fum) | -CH | 6.48/n.o./n.o. | s/n.o./n.o. | -/n.o./n.o. |
| Tyrosine (Tyr) | -CH | 6.83/n.o./n.o. | d/n.o./n.o. | 8.2/n.o./n.o. |
| -CH | 7.12/n.o./n.o. | d/n.o./n.o. | 8.2/n.o./n.o. | |
| Uracil (Ura) | -CH | 7.47/n.o./n.o. | d/n.o./n.o. | 7.68/n.o./n.o. |
| NAD | -CH | 8.12/n.o./n.o. | s/n.o./n.o. | -/n.o./n.o. |
| -CH | 8.37/n.o./n.o. | s/n.o./n.o. | -/n.o./n.o. | |
| Unassigned | 7.52/n.o./n.o. | s/n.o./n.o. | -/n.o./n.o. | |
| 7.84/n.o./n.o. | s/n.o./n.o. | -/n.o./n.o. | ||
*1The left, centre, and right values in the lists are the results obtained from standard JRES, DDFJRES, and MAS, respectively.
*2Multiplet patterns are defined as singlet (s), doublet (d), triplet (t), quartet (q), double doublet (dd), and multiplet (m).
*3n.o. = not observable.
*4NAAG = N-Acetyl aspartate glutamate.
*5Cho/PC/GPC = Choline/Phosphocholine/sn-Glycerophosphocholine.
Figure 3Postmortem study of a whole fish (Siamese algae eater) fitted in a 5-mm NMR tube.
(a–c) 1D water-presaturated, standard 2D water-presaturated JRES, and 2D DDFJRES spectra, respectively at 0.5 h after the sample preparation. (d–f) Spectra corresponding to (a–c) at 72 h after the sample preparation. Metabolite assignments are shown in the 2D DDFJRES spectra. A photo of the sample is provided at the top of the frame.
Assignments of NMR spectra in a postmortem fish (Siamese algae eater) obtained using DDFJRES and standard JRES methods
| DDF | ||||
|---|---|---|---|---|
| Metabolites | Groups | 1H chemical shifts (ppm) | Multiplet patterns | |
| n-3 f.a. | -CH3 | 1.04/n.o. | t/n.o. | 7.8/n.o. |
| All f.a. except 20:5 and 22:6 | -(CH2)n- | 1.39/1.40 | s/s | -/- |
| All f.a. except 22:6 | -CH2-CO | 2.36/n.o. | s/n.o. | -/n.o. |
| Unsaturated f.a. | -N-CH3 | 5.31/5.42 | s/s | -/- |
| Anserine (Ans) | -CH3 | 3.23/n.o. | t/n.o. | 6.5/n.o. |
| Creatine (Cr) | -CH3 | 2.98/3.01 | s/s | -/- |
| -CH2 | 3.89/n.o. | s/n.o. | -/n.o. | |
| Lactate (Lac) | -CH3 | 1.32/n.o. | d/n.o. | 7.2/n.o. |
| -CH | 4.09/n.o. | q/n.o. | 7.2/n.o. | |
| Taurine (Tau) | -CH2 | 3.39/n.o. | t/n.o. | 6.7/n.o. |
| All f.a. except n-3 | -CH3 | 0.92/0.93 | d/t | 6.8/5.3 |
| All f.a. except 20:5 and 22:6 | -(CH2)n- | 1.35/1.37 | s/s | -/- |
| β-Hydroxybutyrate (BHB) | -CH3 | 2.18/n.o. | s/n.o. | -/n.o. |
| Lactate (Lac) | -CH3 | 1.38/n.o. | d/n.o. | 7.3/n.o. |
| Acetate (Ace) | -CH3 | 1.87/1.89 | s/s | -/- |
| Glutamate/Glutamine (Glu/Gln) | -CH2 | 2.04/n.o. | m/n.o. | 7.7/n.o. |
| -CH | 3.70/n.o. | t/n.o. | 7.3/n.o. | |
| Pyruvate (Pyr) | -CH3 | 2.36/2.35 | s/s | -/- |
| Creatine (Cr) | -CH3 | 2.97/2.98 | s/s | -/- |
| -CH2 | 3.82/n.o. | s/n.o. | -/n.o. | |
| Betaine (Bet) | -CH3 | 3.20/3.21 | s/s | -/- |
| Taurine (Tau) | -CH | 3.38/n.o. | t/n.o. | 6.7/n.o. |
| -CH | 3.56/n.o. | dd/n.o. | 10.1&5.4/n.o. | |
| -CH | 3.61/n.o. | dd/n.o. | 9.8&5.5/n.o. | |
| Adenosine (Ade) | -CH | 8.26/n.o. | s/n.o. | -/n.o. |
*1The left and right values in the lists are the results obtained from DDFJRES and standard JRES, respectively.
Figure 4Pulse sequence diagram of DDFJRES.
Gauss-shaped pulses represent solvent-selective RF pulses, full vertical bars indicate non-selective RF pulses, dashed rectangles represent coherence selection gradients, and “SS” indicates the solvent suppression module. The first evolution period t1 consists of the spatially encoded module (bipolar encoding gradients G and relevant adiabatic frequency-swept π pulses), and the acquisition period t3 consists of the spatially decoded module (bipolar decoding gradients G). The second evolution period t2 is a conventional spin echo scheme. G is a pre-acquisition purge gradient. The desired coherence transfer pathway is also given.